Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 18.83% is 34% above its 5-year average of 14.07%, near the low end of its 5-year range (0.48%–2937.51%).
As of the fiscal period ended Tuesday, June 30, 2026. 40.92% above its 12-month average of 13.37%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 18.83%.
DEBT TO ASSETS RATIO
18.83%
DEBT TO ASSETS RATIO AVG TTM
13.37%
DEBT TO ASSETS RATIO AVG 3Y
17.93%
DEBT TO ASSETS RATIO AVG 5Y
14.07%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+40.92%
CURRENT VS 3Y AVG
+5.07%
CURRENT VS 5Y AVG
+33.90%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.11%
median of 529 covered companies
CURRENT VS SECTOR MEDIAN
+17021.70%
vs the sector median at left
bioAffinity Technologies, Inc.
Market Cap
$2.59M
Debt to Assets Ratio
18.83%
TTM Avg
13.37%
3Y Avg
17.93%
5Y Avg
14.07%
Market Cap
$2.47M
Debt to Assets Ratio
0.18%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.38M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.32M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.04M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.13M
Debt to Assets Ratio
0.77%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | $2.59M | 18.83% | 13.37% | 17.93% | 14.07% |
| iSpecimen Inc. (ISPC)vs › | $2.68M | 0.03% | N/A | N/A | N/A |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.47M | 0.18% | N/A | N/A | N/A |
| Jaguar Health, Inc. (JAGX)vs › | $2.74M | 0.49% | N/A | N/A | N/A |
| iTonic Holdings Ltd. (ITOC)vs › | $2.38M | 0.01% | N/A | N/A | N/A |
| GeoVax Labs, Inc. (GOVX)vs › | $2.36M | 0.07% | N/A | N/A | N/A |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.32M | 0.00% | N/A | N/A | N/A |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.04M | 0.01% | N/A | N/A | N/A |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.13M | 0.77% | N/A | N/A | N/A |
| Autonomix Medical, Inc. (AMIX)vs › | $1.92M | 0.00% | N/A | N/A | N/A |
Debt/Assets
18.8%
Debt/Equity
0.38
Current Ratio
1.44
Interest Coverage
-238.3x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 18.83% |
| 2026-03-31 | 17.40% |
| 2025-12-31 | 10.59% |
| 2025-09-30 | 5.90% |
| 2025-06-30 | 14.10% |
| 2025-03-31 | 24.00% |
| 2024-12-31 | 23.05% |
| 2024-09-30 | 26.24% |
| 2024-06-30 | 20.67% |
| 2024-03-31 | 18.57% |
| 2023-12-31 | 19.20% |
| 2023-09-30 | 16.55% |
| 2023-06-30 | 0.48% |
| 2023-03-31 | 1.61% |
| 2022-12-31 | 2.07% |
| 2022-09-30 | 5.80% |
| 2022-06-30 | 1182.34% |
| 2022-03-31 | 881.43% |
| 2021-12-31 | 781.97% |
| 2021-09-30 | 2937.51% |
| 2020-12-31 | 6872.47% |
